Archives for August 4, 2010

← 2010

Ampac gains offset by costs

By Nick Taylor

Ampac Fine Chemicals posted a 28 per cent jump in revenues in the third quarter but this was offset by manufacturing inefficiencies and validation costs.

Penwest Q2 revs up, but job cuts likely

By Gareth Macdonald

Penwest Pharmaceuticals raises guidance citing Opana ER royalties, deals and patent settlements as Q2 highlights; but warns that job cuts likely under cost cutting plan.